The company is pursuing a Phase 3 trial in its most exciting pipeline drug, and investors are awaiting potentially exciting ...

Viking has a market value of about $3.5 billion, leaving it room to run if it gains product approvals and then goes on to generate revenue growth. A 10x increase would result in a market cap of $35 ...

It has been about a month since the last earnings report for Viking Therapeutics, Inc. (VKTX). Shares have added about 16.3% in that time frame, outperforming the S&P 500. Will the recent positive ...

Viking SupplyNet expands its portfolio with VGS, a premium lineup of piping connections designed to streamline ...